Kazia Therapeutics
NasdaqCM:KZIA
$ 9,62
+ $2,28 (31,06%)
9,62 $
+$2,28 (31,06%)
End-of-day quote: 04/07/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-9,17
Earnings Per Share
$0,68
Revenue Per Share
100,00%
Gross Margin %
$0,11 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-9,17
Revenue Per Share
$0,68
Gross Margin %
100,00%
Market Cap
$0,11 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2022 2017 2015
EPS Earnings Per Share $-9,17 $-18,61 $-1,14 $-1,20
Earnings Earnings $-16,78M $-27,92M $-0,55M $-0,50M
RPS Revenue Per Share $0,00 $0,68 $0,02 $17,83 $6,76
Revenue Revenue $0,00M $1,25M $0,03M $8,56M $2,84M
OCF Operating Cash Flow $0,00M $-15,16M $-22,76M $0,00M $-5,76M
FCF Free Cash Flow $0,00M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% -123,49% 0,00%
GM % Gross Margin % 0,00% 100,00% 100,00% 100,00% 100,00%
FCFS Free Cash Flow Per Share $0,00 $-7,94 $-17,18 $-24,48 $-24,56
LT Debt Long-Term Debt N/A N/A N/A N/A N/A
Sha. Stocks 1,83M 1,83M 1,5M 0,48M 0,42M
×